Absence of biallelic TCRgamma deletion predicts early treatment failure in pediatric T-cell acute lymphoblastic leukemia
about
The Functional Role of PRC2 in Early T-cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL) - Mechanisms and OpportunitiesUse of single nucleotide polymorphism array technology to improve the identification of chromosomal lesions in leukemiaNOTCH1 signaling promotes human T-cell acute lymphoblastic leukemia initiating cell regeneration in supportive nichesImmature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged T-cell receptors.Repression of BIM mediates survival signaling by MYC and AKT in high-risk T-cell acute lymphoblastic leukemia.Maturation stage of T-cell acute lymphoblastic leukemia determines BCL-2 versus BCL-XL dependence and sensitivity to ABT-199FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitorsHigh-risk pediatric acute lymphoblastic leukemia: to transplant or not to transplant?Beyond the 2008 World Health Organization classification: the role of the hematopathology laboratory in the diagnosis and management of acute lymphoblastic leukemiaPromoter DNA methylation pattern identifies prognostic subgroups in childhood T-cell acute lymphoblastic leukemiaThe BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia.Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia.Complete hematologic response of early T-cell progenitor acute lymphoblastic leukemia to the γ-secretase inhibitor BMS-906024: genetic and epigenetic findings in an outlier case.Prognostic relevance of integrated genetic profiling in adult T-cell acute lymphoblastic leukemia.The molecular basis of T cell acute lymphoblastic leukemiaEarly T-cell precursor acute lymphoblastic leukaemia.Array comparative genomic hybridization in pediatric acute leukemias.Predicting relapse risk in childhood acute lymphoblastic leukaemia.Molecular genetics of childhood, adolescent and young adult non-Hodgkin lymphoma.Pediatric T-cell acute lymphoblastic leukemia.Immunophenotypic analysis of T-acute lymphoblastic leukemia. A CD5-based ETP-ALL perspective of non-ETP T-ALL.Shared acquired genomic changes in zebrafish and human T-ALL.Absence of biallelic TCRγ deletion predicts induction failure and poorer outcomes in childhood T-cell acute lymphoblastic leukemia.APOBEC signature mutation generates an oncogenic enhancer that drives LMO1 expression in T-ALLATP Binding Cassette C1 (ABCC1/MRP1)-mediated drug efflux contributes to disease progression in T-lineage acute lymphoblastic leukemia.HOXA-activated early T-cell progenitor acute lymphoblastic leukemia: predictor of poor outcome?Microarray-based genomic profiling as a diagnostic tool in acute lymphoblastic leukemia.Acute myeloid/T-lymphoblastic leukaemia (AMTL): a distinct category of acute leukaemias with common pathogenesis in need of improved therapy.High-throughput sequencing detects minimal residual disease in acute T lymphoblastic leukemia.JDP2: An oncogenic bZIP transcription factor in T cell acute lymphoblastic leukemia.
P2860
Q26744506-74F97014-63D7-418D-8503-C36087123BFFQ28390558-81C4D22F-E6EF-43AB-8F17-E3618FEEF778Q28727674-4A6CC560-CEFC-4593-8E26-4E6BF31C1969Q33558120-E9182EB2-D584-40A9-9A5E-3421AACE16C1Q34071295-22B10644-A506-40A3-9321-BE984B3F6F8AQ34135298-50DAA2C3-128C-4055-8F99-BF1EB1D429E8Q34566158-2FF9DA93-5A69-457B-A967-422A5B972A6EQ34645259-0F952604-7974-4961-A81C-EE89E9181A79Q34755687-C20D6EB6-53B4-480C-8EDE-02430A25DF67Q34769855-723719FC-AA29-4A75-9D73-8F6B9CCE81E0Q35483684-4A13C17A-8E34-4757-A471-7A2A80D02A9EQ36174127-21D6A0AB-DE9A-4C0C-9A1F-8FC795F1225CQ36851425-984D11F4-17BB-4467-A6AE-567AE1D73EF1Q36983745-82D46D05-800C-4F3C-AA59-81C7149F37CCQ38047834-19712FC5-489A-4124-8E96-48DCE17102C8Q38108514-1AD5A0AE-5EE2-4D41-A515-C4100D89A284Q38113815-C5E100D1-75E6-4F21-B8C1-186702A1670DQ38117685-75B9B877-C4C3-4286-8027-3710E692198AQ38771110-D2DA69C1-8051-4E64-9D93-662ACF0AA640Q38956273-5F40E416-220A-441E-8627-772730177741Q39296606-F1C24E24-D89E-4C9A-B81D-52A266F30C93Q39632012-F86748C2-C7D7-449C-B500-945F532A8804Q39674477-7B323D0A-C2DB-4B95-8375-6E6838651413Q41932009-3C6FBFDA-0224-44A6-9575-8C0B205AB354Q42203233-23C60360-C946-4D9B-8E1D-864897186D02Q42397478-44AA2873-602D-4C91-83CF-2EDA5BC8AC4DQ43488736-CC2D100D-65B7-4FDF-9489-73A96ED687E9Q50020680-A33ABB0F-E10A-4705-95DE-D689DBB58F5FQ54309630-E6042B98-8FC7-4178-B09F-3CA819177B00Q55516451-CE290387-06A5-467A-91BA-3418CA9ABAB1
P2860
Absence of biallelic TCRgamma deletion predicts early treatment failure in pediatric T-cell acute lymphoblastic leukemia
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Absence of biallelic TCRgamma ...... l acute lymphoblastic leukemia
@ast
Absence of biallelic TCRgamma ...... l acute lymphoblastic leukemia
@en
Absence of biallelic TCRgamma ...... l acute lymphoblastic leukemia
@nl
type
label
Absence of biallelic TCRgamma ...... l acute lymphoblastic leukemia
@ast
Absence of biallelic TCRgamma ...... l acute lymphoblastic leukemia
@en
Absence of biallelic TCRgamma ...... l acute lymphoblastic leukemia
@nl
prefLabel
Absence of biallelic TCRgamma ...... l acute lymphoblastic leukemia
@ast
Absence of biallelic TCRgamma ...... l acute lymphoblastic leukemia
@en
Absence of biallelic TCRgamma ...... l acute lymphoblastic leukemia
@nl
P2093
P2860
P50
P356
P1476
Absence of biallelic TCRgamma ...... l acute lymphoblastic leukemia
@en
P2093
A Thomas Look
Adolfo A Ferrando
Alexei Protopopov
Donna S Neuberg
Jeffery Kutok
Jianhua Zhang
Lewis B Silverman
Lynda Chin
Michael J Borowitz
Mignon L Loh
P2860
P304
P356
10.1200/JCO.2010.28.3390
P407
P577
2010-07-19T00:00:00Z